Erythropoetin


Indications and Reactions:

Role Indications Reactions
Secondary
Hepatitis C 70.6%
Product Used For Unknown Indication 29.4%
Abdominal Distension 33.3%
Death 33.3%
Intestinal Dilatation 33.3%
Concomitant
Drug Use For Unknown Indication 25.2%
Product Used For Unknown Indication 22.6%
Hypertension 8.8%
Nuclear Magnetic Resonance Imaging 7.4%
Multiple Myeloma 7.0%
Anaemia 5.4%
Hyperparathyroidism Secondary 3.3%
Prophylaxis 2.9%
Diffuse Large B-cell Lymphoma 2.2%
Anticoagulant Therapy 1.7%
Nephrogenic Anaemia 1.6%
Breast Cancer 1.4%
Dyspepsia 1.4%
Hepatitis C 1.4%
Renal Failure 1.4%
Renal Transplant 1.3%
Rheumatoid Arthritis 1.3%
Cachexia 1.2%
Nausea 1.2%
Pain 1.2%
Vomiting 9.6%
Anaemia 8.2%
Liver Function Test Abnormal 6.8%
Renal Failure 6.8%
Skin Ulcer 6.8%
Weight Decreased 6.8%
Nephrogenic Systemic Fibrosis 5.5%
Transaminases Increased 5.5%
Myelodysplastic Syndrome 4.1%
Pyrexia 4.1%
Renal Failure Acute 4.1%
Renal Impairment 4.1%
Rhabdomyolysis 4.1%
Sepsis 4.1%
Splenomegaly 4.1%
Thrombocytopenia 4.1%
Aplasia Pure Red Cell 2.7%
Atrioventricular Block Complete 2.7%
Cardiac Pacemaker Insertion 2.7%
Cerebrovascular Accident 2.7%

Drug Data